Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 223-234

  Yew, Nelson S ^a   Wang, Kathryn X ^a   Przybylska, Malgorzata ^a   Bagley, Rebecca G ^a   Stedman, Margaret ^a   Marshall, John ^a   Scheule, Ronald K ^a   Cheng, Seng H ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CATION; CD11B ANTIGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; CYTOKINE; CYTOSINE; DINUCLEOTIDE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PLASMID DNA; POLYMER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; DNA SEQUENCE; DOSE RESPONSE; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; IMMUNOSTIMULATION; INFLAMMATION; LUNG DISEASE; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; SITE DIRECTED MUTAGENESIS; TRANSGENE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CATIONS; CPG ISLANDS; DNA; DNA METHYLATION; INTERFERON TYPE II; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHILS; PLASMIDS; PNEUMONIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033585425     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019011     Document Type: Article

References (29)

1. ALTON, E.W.F.W., GEDDES, D.M., GILL, D.R., HIGGINS, C.F., HYDE, S.C., INNES, J.A., and PORTEOUS, D.J. (1998). Towards gene therapy for cystic fibrosis: A clinical progress report. Gene Ther. 5, 291-292.
2. BALLAS, Z.K., RASMUSSEN, W.L., and KRIEG, A.M. (1996). Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1845.
3. BIRD, A.P. (1993). Functions for DNA methylation in vertebrates. Cold Spring Harb. Symp. Quant. Biol. 58, 281-285.
4. BOYLES, J., and BIRD, A. (1991). DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64, 1123-1134.
5. COWDERY, J.S., CHACE, J.H., YI, A.K., and KRIEG, A.M. (1996). Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of liposaccharides. J. Immunol. 156, 4570-4575.
6. DAVIS, H.L., WEERANTA, R., WALDSCHMIDT, T.J., TYGRETT, L., SCHORR, J., and KRIEG, A.M. (1998). CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870-876.
7. EASTMAN, S.J., LUKASON, M.J., TOUSIGNANT, J.D., MURRAY, H., LANE, M.D., ST. GEORGE, J.A., AKITA, G.Y., CHERRY, M., CHENG, S.H., and SCHEULE, R.K. (1997). A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung. Hum. Gene Ther. 8, 765-773.
8. FREIMARK, B.D., BLEZINGER, H.P., FLORACK, V.J., NORDSTROM, J.L., LONG, S.D., DESHPANDE, D.S., NOCHUMSON, S., and PETRAK, K.L. (1998). Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes. J. Immunol. 160, 4580-4586.
9. GRIBAUDO, G., RAVAGHIA, S., CALIENDO, A., CAVALLO, R., GARIGLIO, M., MARTINOTTI, M.G., and LANDOLFO, S. (1993). Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197, 303-311.
10. GROUDINE, M., EISENMAN, R., and WEINTRAUB, H. (1981). Chromatin structure of endogenous retroviral vector genes and activation by an inhibitor of DNA methylation. Nature (London) 292, 311-317.
11. HARMS, J.S., and SPLITTER, G.A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
12. KLINMAN, D.M., YI, A.K., BEAUCAGE, S.L., CONOVER, J., and KRIEG, A.M. (1996). CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12, and interferon-gamma. Proc. Natl. Acad. Sci. U.S.A. 93, 2879-2883.
13. KRIEG, A.M. (1995). Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol. 4, 73-76.
14. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in baterial DNA trigger direct B-cell activation. Nature (London) 374, 546-549.
15. KRIEG, A.M., WU, T., WEERATNA, R., EFLER, S.M., LOVEHOMAN, L., YANG, L., YI, A.K., SHORT, D., and DAVIS, H.L. (1998). Sequence motifs in adenoviral DNA which block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. U.S.A. 95, 12631-12636.
16. LEE, E.R., MARSHALL, J., SIEGEL, C.S., JIANG, C., YEW, N.S., NICHOLS, M., NIETUPSKI, J., ZIEGLER, R.J., LANE, M., WANG, K.X., WAN, N.C., SCHEULE, R.K., HARRIS, D.J., SMITH, A.E., and CHENG, S.H. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701-1717.
17. LI, E., BEARD, C., and JAENISCH, R. (1993). Role for DNA methylation in genomic imprinting. Nature (London) 366, 362-265.
18. LIPFORD, G.B., BAUER, M., BLANK, C., REITER, R., WAGNER, H., and HEEG, K. (1997). CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340-2344.
19. MUIZNIEKS, I., and DOERFLER, W. (1994). The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: A comparative study. FEBS Lett. 344, 251-254.
20. QIN, L., DING, Y., PAHUD, D.R., CHANG, E., IMPERIALE, M.J., and BROMBERG, J.S. (1997). Promoter attenuation in gene therapy: Interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum. Gene Ther. 8, 2019-2029.
21. ROMAN, M., MARTIN-OROZCO, E., GOODMAN, J.S., NGUYEN, M.D., SATO, Y., RONAGHY, A., KORNBLUTH, R.S., RICHMAN, D.D., CARSON, D.A., and RAZ, E. (1997). Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3, 849-854.
22. SATO, Y., ROMAN, M., TIGHE, H., LEE, D., CORR, M., NGUYEN, M.D., SILVERMAN, G.J., LOTZ, M., CARSON, D.A., and RAZ, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
23. SCHEULE, R.K., ST. GEORGE, J.A., BAGLEY, R.G., MARSHALL, J., KAPLAN, J.M., AKITA, G.Y., WANG, K.X., LEE, E.R., HARRIS, D.J., JIANG, C., YEW, N.S., SMITH, A.E., and CHENG, S.H. (1997). Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8, 689-707.
24. SCHWARTZ, D.A., QUINN, T.J., THORNE, P.S., SAYEED, S., YI, A.K., and KRIEG, A.M. (1997). CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100, 68-73.
25. SPARWASSER, T., MIETHKE, T., LIPFORD, G., ERDMANN, A., HACKER, H., HEEG, K., and WAGNER, H. (1997). Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27, 1671-1679.
26. SPARWASSER, T., KOCH, E.S., VABULAS, R.M., HEEG, K., LIPFORD, G.B., ELIWART, J.W., and WAGNER, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-1054.
27. WEINER, G.J., LIU, H.M., WOOLDRIDGE, J.E., DAHLE, C.E., and KRIEG, A.M. (1997). Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. U.S.A. 94, 10833-10837.
28. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
29. YEW, N.S., WYSOKENSKI, D.M., WANG, K.X., ZIEGLER, R.J., MARSHALL, J., McNEILLY, D., CHERRY, M., OSBURN, W., and CHENG, S.H. (1997). Optimization of plasmid vectors for high-level expression in lung epithelial cells. Hum. Gene Ther. 8, 575-584.